WAM
ACAD icon

Wolverine Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Wolverine Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-51
Closed -$11K – 1197
2015
Q4 		$11K Hold
51
– – ﹤0.01% 1393
2015
Q3 		$19K Sell
51
-9
-15% -$374 ﹤0.01% 1460
2015
Q2 		$47K Sell
60
-25
-29% -$968 ﹤0.01% 1317
2015
Q1 		$31K Buy
+85
New +$2.92K ﹤0.01% 1354
2014
Q4 		– Sell
-54
Closed -$19K – 2102
2014
Q3 		$19K Buy
+54
New +$1.26K ﹤0.01% 1820

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wolverine Asset Management's ACAD Position: Q1 2021 in Review

Wolverine Asset Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2021, closing a stake of 2,244 shares — an estimated $119K sold.

Wolverine Asset Management first reported a position in ACAD in Q2 2013 and held it in 7 quarters. The position peaked at $464K in Q4 2013. 271 funds tracked by Wall St. Rank hold ACAD as of Q1 2021.

  • Wolverine Asset Management reported no remaining Acadia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 2,244 Acadia Pharmaceuticals shares in Q1 2021, an estimated $119K.
  • Wolverine Asset Management first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Wolverine Asset Management's Acadia Pharmaceuticals position peaked at $464K in Q4 2013.
  • 271 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2021.

Based on Wolverine Asset Management's 13F filing for Q1 2021, filed 13 May 2021.